Skip to content

Medical emergency? What to do

U.S. FDA plans tracking of drug safety reviews

3-RXPublished April 19, 20061 min read

Key points

  • Food and Drug Administration needs a way to track the hundreds of internal safety reviews completed each year about drugs already on the market, an agency official said on Tuesday.
  • Analysts in the FDA's Office of Drug Safety provide about 600 reports a year about potential concerns from marketed prescription drugs to officials in another office, the Office of New Drugs.
  • By keeping a tally of the reports and their outcomes, "my hope is this will lead to greater confidence by all in the (FDA's) ability to really stay on top of emerging safety concerns," he said.
  • Some staff in the FDA's Office of Drug Safety have complained that their concerns about Vioxx and other drugs were downplayed or not fully investigated.

The U.S. Food and Drug Administration needs a way to track the hundreds of internal safety reviews completed each year about drugs already on the market, an agency official said on Tuesday.

Dr. Paul Seligman said building such a system would be one of his priorities as he takes the newly created position of associate director for safety policy and communication in the FDA's Center for Drug Evaluation and Research.

Analysts in the FDA's Office of Drug Safety provide about 600 reports a year about potential concerns from marketed prescription drugs to officials in another office, the Office of New Drugs.

"At present, we have really no mechanism for tracking these reviews and ensuring that the conclusions and recommendations that come out of these reviews are adequately addressed," Seligman told reporters.

By keeping a tally of the reports and their outcomes, "my hope is this will lead to greater confidence by all in the (FDA's) ability to really stay on top of emerging safety concerns," he said.

The effort is the latest FDA move to address criticism of its past handling of drug safety issues, including concerns about heart damage from Merck & Co. Inc.'s arthritis pill Vioxx. The company pulled the drug from the market in September 2004.

Some staff in the FDA's Office of Drug Safety have complained that their concerns about Vioxx and other drugs were downplayed or not fully investigated.

Seligman has directed the FDA's Office of Pharmacoepidemiology and Statistical Science since 2001.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.